Pilot Study of Lenalidomide and Dexamethasone in Combination With MEDI-551 in Previously Untreated Multiple Myeloma.
Phase of Trial: Phase 0
Latest Information Update: 12 Sep 2018
At a glance
- Drugs Dexamethasone (Primary) ; Inebilizumab (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 06 Sep 2018 Status changed from active, no longer recruiting to completed.
- 27 Sep 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 27 Sep 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History